Top Markets
Coin of the day
Jenscare Scientific Co., Ltd. Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd.

9877
Clasificación en acciones #15055
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise... Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Precio por acción
$0.90187992
Capitalización bursátil
$376.23M
Cambio (1 día)
-2.69%
Cambio (1 año)
-14.56%
País
CN
Comercio Jenscare Scientific Co., Ltd. (9877)

Categoría

Historial de dividendos de Jenscare Scientific Co., Ltd. (9877)
Jenscare Scientific Co., Ltd. (símbolo bursátil: 9877) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Jenscare Scientific Co., Ltd. (9877) desde 2026 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
Not enough data for the provided dates.
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
Not enough data for the provided dates.
Pagos de dividendos de empresas similares o competidoras